Therapeutic Prospects of Faricimab Injection for Patients Affected by Neovascular Age-Related Macular Degeneration

NCT07088445 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Neovascular Age-related Macular Degeneration(nAMD)

Interventions

DRUG: Faricimab

Sponsor

Hui Peng